Companies/Radient Technologies Inc.

Company profile

Radient Technologies Inc.

OTC: RDDTF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Edmonton, ABReports USD

#751 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

——

FH —DQ —GM —SS 34

v0.1 · 5/100 weight · pillars only

↑ 3-yr revenue growth, revenue growth (YoY) · ↓ growth stability, market scale

Methodology →

Revenue TTM

$2.4M

Rev growth YoY (TTM)

-24.0%

Net income (FY)

-$10.3M

Employees

Market cap

$5.4k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$2.9M3.6M CAD2022

Net income-$10.3M-12.9M CAD2022

Operating income-$5.3M-6.6M CAD2022

Total assets$22.2M27.7M CAD2022

Liabilities$30.3M37.9M CAD2022

Equity-$8.1M-10.1M CAD2022

Revenue trend

FY2017 – FY2022 · USD

$221.7k

FY17

$355.0k

FY18

$163.2k

FY19

$13.8M

FY20

$1.9M

FY21

$2.9M

FY22

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Radient Technologies Inc. booked $2.9M in FY2022 revenue, growing 53% year over year — faster than most Healthcare companies we track, at a -357.0% net margin.

Peers · Healthcare

Panacos Pharmaceuticals, Inc.——LadRx Corporation——Better Therapeutics, Inc.——Bangi Inc.——

Key facts

CEOPrakash Hariharan

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersEdmonton, AB

ExchangeOTC: RDDTF

Employees33

IPO date2016-12-28

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.